Abstract
Colchicine site binders—blockers of tubulin polymerization—are potential antimitotic agents for anticancer therapy. To reduce their systemic toxicity and improve biodistribution, encapsulation in nanosized liposomes may be employed. Liposomes present a convenient means for preparation of injectable for-mulations of hydrophobic compounds, however colchicine as such is known to leak through the lipid bilayer. In this study, newly synthesized triazole-containing analogues of colchicine and allocolchicine, and their palmitic and oleic esters (lipophilic prodrugs) were tested for anti-proliferative activity and apoptosis-inducing potential. In contrast to colchicine conjugates, whose activities ranged with those of colchicine, allocolchicine derivatives exhibited drastically lower effects and were discarded. Liposomes of about 100 nm in diameter composed of egg phosphatidylcholine-yeast phosphatidylinositol-palmitic or oleic prodrug, 8: 1: 1, by mol, were prepared by standard extrusion technique and tested in a panel of four human tumor cell lines. Liposome formulations preserved the biological activities of the parent colchicinoid the most towards human epithelial tumor cells. Moreover, liposomal form of the oleoyl bearing colchicinoid inhibited cell proliferation more efficiently than free lipophilic prodrug. Due to substantial loading capacity of the liposomes, the dispersions contain sufficient concentration of the active agent to test wide dose range in experiments on systemic administration to animals.
Similar content being viewed by others
Abbreviations
- EPR:
-
enhanced permeability and retention
- PEG:
-
polyethylene glycol
- LDH:
-
lactate dehydrogenase
- PC:
-
phosphatidylcholine
- PI:
-
phosphatidylinositol
- PBS:
-
phosphate buffered saline
- DAPI:
-
4′,6-diamidino-2-phenylindol
- EGTA:
-
ethylene glycol tetraacetic acid
- PIPES:
-
piperazine-N,N-bis(2-ethanesulfonic acid)
References
Li, Q. and Sham, H.L., Expert Opin. Ther. Pat., 2002, vol. 12, pp. 1663–1702.
Bhattacharyya, B., Panda, D., Gupta, S., and Banerjee, M., Med. Res. Rev., 2008, vol. 28, pp. 155–183.
Tron, G.C., Pirali, T., Sorba, G., Pagliai, F., Busacca, S., and Genazzani, A., J. Med. Chem, 2006, vol. 49, pp. 3033–3044.
Buttner, F., Bergemann, S., Guenard, D., Gust, R., Seitz, G., and Thoret, S., Bioorg. Med. Chem., 2005, vol. 13, pp. 3497–3511.
Allen, T.M. and Cullis, P.R., Science, 2004, vol. 303, pp. 1818–1822.
Maeda, H., Sawa, T., and Konno, T., J. Controlled Release, 2001, vol. 74, pp. 47–61.
Zucker, D., Marcus, D., Barenholz, Y., and Goldblum, A., J. Controlled Release, 2009, vol. 139, pp. 73–80.
Mons, S., Veretout, F., Carlier, M.F., Erk, I., Lepault, J., Trudel, E., Salesse, C., Ducray, P., Mioskowski, C., and Lebeau, L., Biochim. Biophys. Acta, 2000, vol. 1468, pp. 381–395.
Crielaard, B.J., van der Wal, S., Le, H.T., Bode, A.T.L., Lammers, T., Hennink, W.E., Schiffelers, R.M., Fens, M.H., and Storm, G., Eur. J. Pharm. Sci., 2012, vol. 45, pp. 429–435.
Schwendener, R. and Schott, H., Methods, Enzymol., 2005, vol. 391, pp. 58–70.
Crosasso, P., Brusa, P., Dosio, F., Arpicco, S., Pacchioni, D., Schuber, F., and Cattel, L., J. Pharm. Sci., 1997, vol. 86, pp. 832–839.
Immordino, M.L., Brusa, P., Rocco, F., Arpicco, S., Ceruti, M., and Cattel, L., J. Controlled Release, 2004, vol. 100, pp. 331–346.
Gabizon, A., Amitay, Y., Tzemach, D., Gorin, J., Shmeeda, H., and Zalipsky, S., J. Controlled Release, 2012, vol. 160, pp. 245–253.
Vodovozova, E.L., Moiseeva, E.V., Grechko, G.K., Gayenko, G.P., Nifant’ev, N.E., Bovin, N.V., and Molotkovsky, J.G., Eur. J. Cancer, 2000, vol. 36, pp. 942–949.
Nicolaus, N., Reball, J., Sitnikov, N., Velder, J., Termath, A., Fedorov, A.Yu., and Schmalz, H.-G., Heterocycles, 2011, vol. 82, pp. 1585–1600.
Nicolaus, N., Janet, Z., Riesterer, P., Neudorfl, J.-M., Prokop, A., Oschkinat, H., and Schmalz, H.-G., Chem. Med. Chem., 2010, vol. 5, pp. 661–665.
Liederer, B.M. and Borchardt, R.T., J. Pharm. Sci., 2006, vol. 95, pp. 1177–1195.
Wieder, T., Prokop, A., Bagci, B., Essmann, F., Bernicke, D., Schulze-Osthoff, K., Dorken, B., Schmalz, H.G., Daniel, P.T., and Henze, G., Leukemia, 2001, vol. 15, pp. 1735–1742.
Mayer, L.D., Hope, M.J., and Cullis, P.R., Biochim. Biophys. Acta, 1986, vol. 858, pp. 161–168.
Kuznetsova, N., Kandyba, A., Vostrov, I., Kadykov, V., Gaenko, G., Molotkovsky, J., and Vodovozova, E., J. Drug Deliv. Sci. Techn., 2009, vol. 19, pp. 51–59.
Gabizon, A. and Papahadjopoulos, D., Proc. Natl. Acad. Sci. U.S.A., 1988, vol. 85, pp. 6949–6953.
Muller, M., Zschornig, O., Ohki, S., Arnold, K., J. Membrane Biol., 2003, vol. 192, pp. 33–43.
Moghimi, S.M., Andersen, A.J., Hashemi, S.H., Lettiero, B., Ahmadvand, D., Hunter, A.C., Andresen, T.L., Hamad, I., and Szebeni, J., J. Controlled Release, 2010, vol. 146, pp. 175–181.
Mosmann, T.J., Immunol. Methods, 1983, vol. 65, pp. 55–63.
Sahay, G., Alakhova, D.Y., and Kabanov, A.V., J. Controlled Release, 2010, vol. 145, pp. 182–195.
Menezes, D.E.L., Kirchmeier, M.J., Gagne, J.F., Pilarski, L.M., and Allen, T.M., J. Liposome Res., 1999, vol. 9, pp. 199–228.
Shmeeda, H., Amitay, Y., Gorin, J., Tzemach, D., Mak, L., Ogorka, J., Kumar, S., Zhang, J.A., and Gabizon, A., J. Controlled Release, 2010, vol. 146, pp. 76–83.
Bartlett, G.R., J. Biol. Chem., 1959, vol. 234, pp. 466–468.
Bonne, D., Heusele, C., Simon, C., and Pantaloni, D., J. Biol. Chem., 1985, vol. 260, pp. 2819–2825.
Author information
Authors and Affiliations
Corresponding author
Additional information
The article is published in the original.
Rights and permissions
About this article
Cite this article
Kuznetsova, N.R., Svirshchevskaya, E.V., Sitnikov, N.S. et al. Lipophilic prodrugs of a triazole-containing colchicine analogue in liposomes: Biological effects on human tumor cells. Russ J Bioorg Chem 39, 543–552 (2013). https://doi.org/10.1134/S1068162013050105
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162013050105